Role of severe thrombocytopenia in preventing platelet count recovery in thrombocytopenic patients with chronic liver disease-Reference-Cited by-同舟云学术

Role of severe thrombocytopenia in preventing platelet count recovery in thrombocytopenic patients with chronic liver disease

Published:2019-08-16 Issue:2 Volume:35 Page:299-304
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Hirooka Masashi¹^ORCID,Ochi Hironori²,Hiraoka Atsushi³,Koizumi Yohei¹,Tanaka Takaaki¹,Sunago Kotaro¹,Yukimoto Atsushi¹,Imai Yusuke¹,Watanabe Takao¹,Yoshida Osamu¹,Abe Masanori¹,Joko Kouji²^ORCID,Michitaka Kojiro³,Hiasa Yoichi¹

Affiliation:

1. Department of Gastroenterology and MetabologyEhime University Graduate School of Medicine Toon Japan

2. Center for Liver‐Biliary‐Pancreatic DiseasesMatsuyama Red Cross Hospital Matsuyama Japan

3. Gastroenterology CenterEhime Prefectural Central Hospital Matsuyama Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.14786

Reference15 articles.

1. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options

2. Thrombocytopenia associated with chronic liver disease

3. Efficacy of Repeated Lusutrombopag Administration for Thrombocytopenia in a Patient Scheduled for Invasive Hepatocellular Carcinoma Treatment

4. A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation

5. Current issues with platelet transfusion in patients with cancer

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lusutrombopag Reduces the Risk of Hemoperitoneum Caused by Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma Compared with Platelet Transfusion;Digestive Diseases;2024-04-25

2. The evolving knowledge on primary hemostasis in patients with cirrhosis: A comprehensive review;Hepatology;2023-02-27

3. A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series;Medicine;2022-11-04

4. Relationship between baseline clinical characteristics and efficacy of lusutrombopag in thrombocytopenic patients with chronic liver disease: post hoc analysis of two placebo-controlled phase 3 trials;Current Medical Research and Opinion;2021-12-22

5. Relationship between Hepatitis B virus infection and platelet production and dysfunction;Platelets;2021-11-21